Delivery Order SPE2DB25D3201-SPE2DB25FNVVS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 tablets, with a ceiling value of $4,397.88. This non-competitive, firm fixed-price delivery order is set to be completed by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on September 15, 2025, with a ceiling value of $42,385.52. This firm fixed-price delivery order, which is expected to be completed by September 16, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was competitively awarded without set-aside provisions, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for Terbinafine HCL 250 mg tablets (30-count) with a ceiling value of $1,015.23. This firm fixed-price delivery order, which is not set-aside, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $5,072.07. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor based on standard federal procurement practices. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the order is scheduled...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count) with a contract ceiling value of $7,834.63. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100s, with a ceiling value of $11,707.25. The delivery order represents a firm fixed price, competitive award with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at approximately $39,194 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 27, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 90, valued at $1,118.65 under a firm fixed-price contract. This non-set-aside delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. As a child contract action, this award falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVVSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $3,320.50. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical transactional delivery against AmerisourceBergen's substantial existing contract portfolio with DLA. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which carries a total value of $999,999,999 and extends through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, maintaining a comprehensive product portfolio spanning generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's DLA relationships position it as a primary supplier supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/22/25 |